The FDA has accepted the supplemental new drug application (sNDA) from Arcutis Biotherapeutics, Inc. for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in adults and children down to age 6. The FDA assigned the application a Prescription Drug User...
By Joe Gorelick, MSN, FNP-C The ability to treat food allergy with oral immunotherapy could be closer to clinical reality. The FDA has granted Fast Track Designation for ADP101, an investigational multi-food oral immunotherapy (mOIT) from Alladapt Immunotherapeutics,...
Kristine Kucera, PA-C, MPAS, DHS Treating pediatric patients with inflammatory skin disease often can be challenging. Without published treatment guidelines, clinicians may be uncomfortable prescribing methotrexate (MTX) in this population. To address this...
Therapeutic decision-making for vascular lesions in children presents several challenges. An accurate diagnosis is fundamental to the process, but then there are other issues to consider, according to Sheila Fallon Friedlander, M.D. who spoke to colleagues this past...
The use of olive or sunflower oil on newborn babies’ skin damages the skin barrier, researchers from the University of Manchester recently reported.1 This latest study adds to the conflicting information around caring for newborn skin and how to manage conditions like...